TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
The Jakarta Post
PREMIUM SUBSCRIPTION
press enter to search

PREMIUM SUBSCRIPTION

COVID-19-drugs

S. Korea's Green Cross seeks phase 2 trials of COVID-19 plasma drug
World 5 months ago

S. Korea's Green Cross seeks phase 2 trials of COVID-19 plasma drug

South Korea's Green Cross Corp has sought regulatory approval for Phase II trials of an experime...
Canada OKs remdesivir for use against coronavirus
World 5 months ago

Canada OKs remdesivir for use against coronavirus

Canada on Tuesday gave the green light for people with severe symptoms of COVID-19 to be treated wit...
Glenmark's favipiravir version shows promise in late-stage COVID-19 trial
World 5 months ago

Glenmark's favipiravir version shows promise in late-stage COVID-19 trial

India's Glenmark Pharmaceuticals Ltd said on Wednesday its version of anti-flu drug favipiravir ...
Japan approves dexamethasone as coronavirus treatment
World 5 months ago

Japan approves dexamethasone as coronavirus treatment

Japan's health ministry has approved dexamethasone, a cheap and widely used steroid, as a second...
South Korea approves human trials of Celltrion's COVID-19 antibody drug
World 5 months ago

South Korea approves human trials of Celltrion's COVID-19 antibody drug

South Korea on Friday approved an early stage clinical trial of Celltrion Inc's experimental COV...
Hydroxychloroquine ineffective against mild COVID-19, US study shows
World 6 months ago

Hydroxychloroquine ineffective against mild COVID-19, US study shows

The anti-malaria drug touted by US President Donald Trump as a COVID-19 treatment was ineffective fo...
One in three South Korean COVID-19 patients improve with remdesivir
World 6 months ago

One in three South Korean COVID-19 patients improve with remdesivir

One in three South Korean patients seriously ill with COVID-19 showed an improvement in their condit...
EU scrambles to buy intensive care drugs to tackle COVID shortages
World 6 months ago

EU scrambles to buy intensive care drugs to tackle COVID shortages

The European Union is seeking firms to supply 24 intensive care drugs, an EU official told Reuters, ...
Russian firm gets approval for drug said to block coronavirus replication
World 6 months ago

Russian firm gets approval for drug said to block coronavirus replication

It said a clinical trial involving mild or medium-level cases had shown the drug to be highly effect...
Ignoring outrage, Trump makes good on WHO pullout
World 6 months ago

Ignoring outrage, Trump makes good on WHO pullout

President Donald Trump on Tuesday formally started the withdrawal of the United States from the Worl...
The Jakarta Post

Our partners

© 2016 - 2021 PT. Niskala Media Tenggara